SC 13D/A
SCHEDULE 13D/A
- Filing date
- 20 Jan 2023
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,805 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 876-900 of 1,000 matching filings.
Per page
25
Current page
36
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 18 Jan 2023
- Reporting date
- 18 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 17 Jan 2023
- Reporting date
- 17 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 17 Jan 2023
- Reporting date
- 17 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Jan 2023
- Reporting date
- 13 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 12 Jan 2023
- Reporting date
- 12 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 03 Jan 2023
- Reporting date
- 03 Jan 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Dec 2022
- Reporting date
- 22 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Dec 2022
- Reporting date
- 21 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Dec 2022
- Reporting date
- 21 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BOARD AND COMMITTEE CHANGES
- Filing date
- 15 Dec 2022
- Reporting date
- 15 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Dec 2022
- Reporting date
- 13 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
STATEMENT: ZANTAC (RANITIDINE) LITIGATION
- Filing date
- 07 Dec 2022
- Reporting date
- 07 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSFER OF TREASURY SHARES
- Filing date
- 05 Dec 2022
- Reporting date
- 05 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 02 Dec 2022
- Reporting date
- 02 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
JEMPERLI POSITIVE TRIAL IN ENDOMETRIAL CANCER
- Filing date
- 02 Dec 2022
- Reporting date
- 02 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EMA FILE ACCEPTED FOR MOMELOTINIB
- Filing date
- 02 Dec 2022
- Reporting date
- 02 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Dec 2022
- Reporting date
- 01 Dec 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK PUBLISHES PROVISIONAL 2023 DIVIDEND DATES
- Filing date
- 25 Nov 2022
- Reporting date
- 25 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLENREP US UPDATE
- Filing date
- 22 Nov 2022
- Reporting date
- 22 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Nov 2022
- Reporting date
- 21 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLOCK LISTING INTERIM REVIEW
- Filing date
- 15 Nov 2022
- Reporting date
- 15 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 001-38266
3 filing
- Filing date
- 14 Nov 2022
- Reporting date
- 07 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
SCHEDULE 13D/A
- Filing date
- 14 Nov 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK UPDATE: ZEJULA 2L IN US
- Filing date
- 14 Nov 2022
- Reporting date
- 14 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing